Intercytex News
Most Popular Intercytex Story
Pfizer eyes troubled Intercytex for buyout
Despite setbacks, Intercytex is working hard to stay in the game. The troubled U.K. biotech saw it shares jump 30 percent today on the news that Pfizer is among the company's suitors. The interest Read more...
Latest Headlines
- September 11, 2009
- May 26, 2009
- February 23, 2009
- January 26, 2009
- August 1, 2005
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
